Promising Thrombin Biomarkers For Identifying High-Risk VTE Patients – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Geke C. Poolen et al, adding:
”Thrombin Generation and Thrombin Dynamics Are Associated with Recurrent Venous Thromboembolism After Anticoagulation Withdrawal
In 589 VTE patients, reduced endogenous thrombin potential, thrombomodulin sensitivity, and thrombin inactivation by antithrombin were significantly associated with VTE recurrence after stopping anticoagulation, highlighting these parameters as promising biomarkers for identifying high-risk patients.”
Title: Thrombin generation and thrombin dynamics are associated with recurrent venous thromboembolism after anticoagulation withdrawal
Authors: Geke C. Poolen, Romy M.W. de Laat-Kremers, Mark Roest, Geert-Jan Geersing, Rolf T. Urbanus, Bas de Laat, Roger E.G. Schutgens
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery